SUMMARY
Sickle cell anaemia is caused by a recessive point mutation in the beta chain of adult haemoglobin, specifically the homozygous HBSS genotype. However, fetuses with homozygous recessive traits are not affected due to the presence of fetal hemoglobin (HbF), which is primarily composed of gamma chains rather than beta chains. HbF does not polymerize under low oxygen conditions, thus preventing the sickling process associated with the disease. The switch from HbF to HbS occurs after the first few months of life, and individuals with hereditary persistence of fetal hemoglobin often experience milder disease symptoms.
PREREQUISITES
- Understanding of sickle cell genetics and inheritance patterns
- Knowledge of hemoglobin types: HbF and HbS
- Familiarity with the physiological effects of hemoglobin polymerization
- Basic concepts of fetal development and hemoglobin switching
NEXT STEPS
- Research the genetic mechanisms behind sickle cell disease and its variants
- Study the role of fetal hemoglobin in preventing sickle cell symptoms
- Explore treatments for sickle cell disease, including gene therapy options
- Investigate the implications of hereditary persistence of fetal hemoglobin on disease severity
USEFUL FOR
Medical students, geneticists, hematologists, and healthcare professionals involved in the study and treatment of sickle cell disease and related hemoglobinopathies.